Start for free
Start for free
ZC

Zesiger Capital

North America, New York, United States, New York

Description

Zesiger Capital Group LLC is a New York City based SEC registered money management firm committed to maximizing total returns on assets

Investor Profile

Zesiger Capital has made 7 investments, with 0 in the past 12 months and 14% as lead.

Stage Focus

  • Series D (29%)
  • Series C (14%)
  • Series B (14%)
  • Private Equity (14%)
  • Series Unknown (14%)
  • Series A (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Genetics
  • Computer
  • Hardware
  • Software
  • Medical
  • E-commerce
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zesiger Capital frequently co-invest with?

BP
Biofrontier Partners
North America, California, United States, San Diego
Co-Investments: 2
Mizuho Securities
Mizuho Securities
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
CC
CMEA Capital
North America, California, United States, San Francisco
Co-Investments: 2
BS
BSI SA
Europe, Ticino, Switzerland, Lugano
Co-Investments: 2
PL
Private Life Biomed
Europe, Hamburg, Germany, Hamburg
Co-Investments: 2
CS
Cape Securities
North America, Georgia, United States, Mcdonough
Co-Investments: 2
Maverick Ventures
Maverick Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Glynn Capital Management
Glynn Capital Management
North America, California, United States, Menlo Park
Co-Investments: 2
Brookside Capital
Brookside Capital
North America, California, United States, San Francisco
Co-Investments: 2

What are some of recent deals done by Zesiger Capital?

Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DJan 6, 2006
Amount Raised: $50,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series DFeb 28, 2005
Amount Raised: $74,000,000
LogMatrix

Marlborough, Massachusetts, United States

LogMatrix offers a unique Network and System management solution that enables customers to meet difficult requirements, and adapt quickly

ComputerHardwareSoftware
Series CNov 26, 2003
Amount Raised: $8,000,000
Alexza Pharmaceuticals

Mountain View, California, United States

Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.

BiotechnologyHealth CarePharmaceutical
Series ASep 25, 2002
Amount Raised: $45,000,000
Response Networks

Western Grove, Arkansas, United States

Response Networks offer business communications solutions designed to speed your Response to your clients, partners and prospects.

Communications Infrastructure
Series UnknownSep 25, 2001
Amount Raised: $4,000,000
Cognetix

Salt Lake City, Utah, United States

Cognetix is a biotech company that explored the use of snail toxins for the treatment of epilepsy, pain, and anesthesia.

BiotechnologyMedicalPharmaceutical
Series BJul 31, 2001
Amount Raised: $17,000,000
iAsiaworks

San Mateo, California, United States

iAsiaWorks provides web hosting, and other e-commerce and professional services to businesses in Asia.

E-CommerceInternetProfessional Services
Private EquityDec 15, 1999
Amount Raised: $85,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator